BioKinect Limited Information

BioKinect and SAGEIQ™ combine AI-enabled analytics with 30+ years of life sciences transaction expertise to identify and prioritize high-value partnering, licensing, and M&A opportunities globally. Powered by the SAGENT™ intelligence engine, the platform integrates scientific, clinical, corporate, and deal intelligence to deliver “Partnering Precision™” for pharmaceutical, biotechnology, medical device, and healthcare companies seeking strategic growth and innovation. Intended Audience • Pharmaceutical and biopharma companies • Biotechnology and emerging therapeutics companies • Business development and licensing teams • Corporate strategy and M&A groups • Venture capital and private equity healthcare investors • Medical technology and diagnostics companies • Cell & gene therapy and platform technology developers • Healthcare innovation and strategic partnering executives